Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nina Kostevsek
Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Towards Prodrug-Nanomedicine Design
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Related publications
Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
Science Translational Medicine
Medicine
Analysis of a Conjugate Between Anti-Carcinoembryonic Antigen Monoclonal Antibody and Alkaline Phosphatase for Specific Activation of the Prodrug Etoposide Phosphate
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
The Role of Adenoviral Vectors in Genetic Prodrug Activation Therapy in Prostate Cancer
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Towards Light Activated Ruthenium‐Arene (RAPTA‐type) Prodrug Candidates
ChemBioChem
Organic Chemistry
Biochemistry
Molecular Medicine
Molecular Biology
A Colon-Specific Prodrug of Metoclopramide Ameliorates Colitis in an Experimental Rat Model
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin
Clinical Cancer Research
Cancer Research
Oncology
Design and Discovery of a Novel Dipeptidyl-Peptidase IV (CD26)-Based Prodrug Approach
